Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 3,400.00
+70.00 (2.10%)
At close: Jun 27, 2025, 3:30 PM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 276.77 billion as of June 27, 2025. Its market cap has decreased by -2.38% in one year.
Market Cap
276.77B
Enterprise Value
357.54B
Revenue
6.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,400.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 276.77B, a decrease of -54.87%. That is a compound annual growth rate of -16.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 264.36B | -32.91% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 401.04T |
| SK hynix | 197.44T |
| Samsung Biologics | 71.46T |
| LG Energy Solution | 69.73T |
| Hyundai Motor Company | 47.37T |
| NAVER | 42.22T |
| Doosan Enerbility | 42.14T |
| Hanwha Aerospace | 40.39T |